Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

Wellthy Therapeutics raises $2.1 million for chronic disease care

ImpactAlpha, Mar. 13 – Wellthy Therapeutics, a Mumbai-based digital health startup has developed a smartphone app to help patients learn about and manage chronic diseases, including diabetes.

Early results from its diabetes pilot have reportedly shown that a majority of patients using the app are able to better regulate their blood sugar levels.

Chronic diseases like diabetes are responsible for the highest number of deaths in India and are the biggest cost burden on the country’s healthcare system.

The company raised a seed round from family office Manipal Education and Medical Group, Beenext Ventures, GrowX Ventures, Currae Healthcare and several individuals.

You might also like...